Human Blood; Animal Blood Prepared for Therapeutic Uses, Prophylactic or Diagnostic; Toxins, Cultures of Microorganisms and Similar Products. (Exc. Yeasts and Vaccines)
Código 300290 (Harmonized System 2012 by 6 digits)
Specialization
#permalink to sectionSpecialization by State
#permalink to sectionThe RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Human Blood; Animal Blood Prepared for Therapeutic Uses, Prophylactic or Diagnostic; Toxins, Cultures of Microorganisms and Similar Products. (Exc. Yeasts and Vaccines) and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Human Blood; Animal Blood Prepared for Therapeutic Uses, Prophylactic or Diagnostic; Toxins, Cultures of Microorganisms and Similar Products. (Exc. Yeasts and Vaccines). On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
Global Market
#permalink to sectionOrigins and Trade Destinations
#permalink to section- N/A%, Mexican share in global exports - 2022
- N/A%, Mexican share in global imports - 2022
The visualizations show the global market for Human Blood; Animal Blood Prepared for Therapeutic Uses, Prophylactic or Diagnostic; Toxins, Cultures of Microorganisms and Similar Products. (Exc. Yeasts and Vaccines). In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Human Blood; Animal Blood Prepared for Therapeutic Uses, Prophylactic or Diagnostic; Toxins, Cultures of Microorganisms and Similar Products. (Exc. Yeasts and Vaccines) were N/A. In the same year, the main importing countries for Human Blood; Animal Blood Prepared for Therapeutic Uses, Prophylactic or Diagnostic; Toxins, Cultures of Microorganisms and Similar Products. (Exc. Yeasts and Vaccines) were N/A.